Scintigraphic parameters with emphasis on perfusion appraisal in rest 99mTc-sestamibi SPECT in the recovery of myocardial function after thrombolytic therapy in patients with ST elevation myocardial infarction (STEMI)

Perfusion

Volumn 26, Issue 5, 2011, Pages 409-421

  Javadi, H ^a   Porpiranfar, M A ^b   Semnani, S ^a   Jallalat, S ^a   Yavari, P ^b   Mogharrabi, M ^a   Hooman, A ^b   Amini, A ^c   Barekat, M ^c   Iranpour, D ^c   Seyedabadi, M ^c   Assadi, M ^c   Asli, I N ^b  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c University of Persian Gulf   (Iran)

Author keywords

99mTc sestamibi; acute myocardial infarction; redistribution; streptokinase

Indexed keywords

ENOXAPARIN; HEPARIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; STREPTOKINASE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONVALESCENCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; MALE; PARAMETER; PREDICTION; PRIORITY JOURNAL; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; TREATMENT RESPONSE; CARDIAC GATED IMAGING; ECHOCARDIOGRAPHY; ECHOGRAPHY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY;

ADULT; AGED; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; TECHNETIUM TC 99M SESTAMIBI; THROMBOLYTIC THERAPY; VENTRICULAR FUNCTION, LEFT;

EID: 80052621400     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659111409970     Document Type: Article

References (43)

1. Li QS, Solot G, Frank TL, Wagner HN, Becker LC. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI). J Nucl Med. 1990 ; 31: 1069-1076 (Pubitemid 20186255)
2. Sinusas AJ, Shi Q, Vitols PJ, et al. Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size. Circulation. 1993 ; 88: 2224-2234 (Pubitemid 23326103)
3. Berman DS, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J. Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med. 1991 ; 21: 190-212
4. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation. 1989 ; 80: 1277-1286 (Pubitemid 19282516)
5. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation. 1988 ; 77: 491-498 (Pubitemid 18060058)
6. Sinusas AJ, Watson DD, Cannon JM, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol. 1989 ; 14: 1785-1793 (Pubitemid 20011877)
7. Beanlands RS, Dawood F, Wen WH, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?. Circulation. 1990 ; 82: 1802-1814 (Pubitemid 20367983)
8. Freeman I, Grunwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med. 1991 ; 32: 292-298
9. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation. 1990 ; 82: 1424-1437
10. Sansoy V, Glover DK, Watson DD, et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation. 1995 ; 92: 994-1004
11. Sinusas AJ, Bergin JD, Edwards NC, et al. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis. Circulation. 1994 ; 89: 2332-41
12. Ohtsuki K, Sugihara H, Taniguchi Y, et al. Evaluation of myocardial perfusion and ventricular shape in hypertrophic cardiomyopathy using 99mTc-tetrofosmin scintigraphy: comparison with 201Tl myocardial scintigraphy. Kaku Igaku. 1994 ; 31: 309-18 (Pubitemid 24178656)
13. Weiss AT, Maddahi J, Lew AS, et al. Reverse redistribution of thallium-201: a sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol. 1986 ; 7: 61-7 (Pubitemid 16132456)
14. Biggi A, Farinelli MC, Bruna C, Papaleo A, De Benedictis N, Camuzzini GF. Thallium-201 reverse redistribution at rest: a pattern of myocardial infarction. J Nucl Med Allied Sci. 1987 ; 31: 331-6 (Pubitemid 18047315)
15. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med. 1996 ; 37: 1289-94 (Pubitemid 26330657)
16. Arii T, Naruse H, Sakaki T, et al. Reverse redistribution of technetium-99m-tetrofosmin after acute coronary revascularization in patients with myocardial infarction. J Cardiol. 1999 ; 34: 1-8 (Pubitemid 29357310)
17. Tabatabaee A, Pourbehi MR, Moghaddam M, et al. Comparsion of influence of enoxaparin with unfractioned heparin on acute myocardial infarction with ST-segment elevation. ISMJ. 2010 ; 12: 198-205
18. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004 ; 44: 671-719
19. Roberti RR, Van Tosh A, Baruchin MA, et al. Left ventricular cavity-to-myocardial count ratio: a new parameter for detecting resting left ventricular dysfunction directly from tomographic thallium perfusion scintigraphy. J Nucl Med. 1993 ; 34: 193-198 (Pubitemid 23056395)
20. Neshandar E, Porpiranfar MA, Ghamiri SMR, Javadi H. Role of the left ventricular cavity-to-myocardium count ratio in resting technetium-99m-Sestamibi SPECT in the recovery of myocardial function after thrombolytic therapy in patients with acute myocardial infarction. International Journal of Low Radiation. 2007 ; 4: 33-42 (Pubitemid 47289503)
21. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol. 1988 ; 12: 1573-1581
22. Caforio AL, Mahon NG, Baig MK, et al. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation. 2007 ; 115: 76-83 (Pubitemid 46058614)
23. De Coster PM, Wijns W, Cauwe F, Robert A, Beckers C, Melin JA. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation. 1990 ; 82: 2152-2162
24. Grunwald AM, Watson DD, Holzgrefe HH, Irving JF, Beller GA. Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation. 1981 ; 64: 610-618 (Pubitemid 11061631)
25. Piwnica-Worms D, Chiu ML, Kronauge JF. Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation. 1992 ; 85: 1531-1541
26. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation. 1994 ; 89: 578-587
27. Langer A, Burns RJ, Freeman MR, et al. Reverse redistribution on exercise thallium scintigraphy: relationship to coronary patency and ventricular function after myocardial infarction. Can J Cardiol. 1992 ; 8: 709-715
28. Liu P, Burns RJ. Easy come, easy go: time to pause and put thallium reverse redistribution in perspective. J Nucl Med. 1993 ; 34: 1692-1694 (Pubitemid 23295379)
29. Marin-Neto JA, Marzullo P, Marcassa C, et al. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am J Cardiol. 1992 ; 69: 780-784
30. Silberstein EB, DeVries DF. Reverse redistribution phenomenon in thallium-201 stress tests: angiographic correlation and clinical significance. J Nucl Med. 1985 ; 26: 707-710 (Pubitemid 16005490)
31. Reverse redistribution in Tl-201 stress-redistribution myocardial scintigraphy. Effect of rest reinjection. Clin Nucl Med. 1994 ; 19 (11). 956-961
32. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993 ; 329: 1615-1622
33. Brouwer MA, van den Bergh PJ, Aengevaeren WR, et al. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Circulation. 2002 ; 106: 659-665 (Pubitemid 34851923)
34. Dakik HA, Mahmarian JJ, Kimball KT, Koutelou MG, Medrano R, Verani MS. Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation. 1996 ; 94: 2735-2742 (Pubitemid 26411736)
35. Jain D, Thompson B, Wackers FJ, Zaret BL. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study. J Am Coll Cardiol. 1997 ; 30: 421-429 (Pubitemid 27339321)
36. Sarda L, Fuchs L, Lebtahi R, et al. Prognostic value of 201Tl myocardial scintigraphy after coronary artery bypass grafting. Nucl Med Commun. 2001 ; 22: 189-196 (Pubitemid 32222635)
37. Marcassa C, Galli M, Baroffio C, Eleuteri E, Campini R, Giannuzzi P. Independent and incremental prognostic value of (201)Tl lung uptake at rest in patients with severe postischemic left ventricular dysfunction. Circulation. 2000 ; 102: 1795-1801
38. Leslie WD, Tully SA, Yogendran MS, Ward LM, Nour KA, Metge CJ. Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2005 ; 45: 1676-1682 (Pubitemid 40704506)
39. Georgoulias P, Tsougos I, Valotassiou V, Tzavara C, Xaplanteris P, Demakopoulos N. Long-term prognostic value of early poststress (99m)Tc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2010 ; 37: 789-98
40. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation. 1997 ; 96: 2892-2898 (Pubitemid 27500087)
41. Schneider CA, Voth E, Gawlich S, et al. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds. J Am Coll Cardiol. 1998 ; 32: 648-654 (Pubitemid 28435248)
42. Medrano R, Lowry RW, Young JB, et al. Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation. 1996 ; 94: 1010-1017 (Pubitemid 26292854)
43. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994 ; 89: 2552-2561